Angiopoietin-2 promoter haplotypes confer an increased risk of stroke in a Chinese Han population

Clinical Science

Volumn 117, Issue 11, 2009, Pages 387-395

  Chen, Jingzhou ^a   Yu, Hui ^a   Song, Weihua ^a   Sun, Kai ^a   Song, Yan ^a   Lou, Kejia ^a   Yang, Tao ^a   Zhang, Yinhui ^a   Hui, Rutai ^a,b  

^a Sino German Laboratory for Molecular Medicine   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Angiogenesis; Angiopoietin 2; Cerebrovascular disease; Stroke

Indexed keywords

ANGIOPOIETIN 2; GUANINE; TYROSINE;

ADULT; ALLELE; ANGIOGENESIS; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CHINESE; CONTROLLED STUDY; FEMALE; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HAPLOTYPE; HAPLOTYPE MAP; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; STROKE;

AGED; ANGIOPOIETIN-2; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; RISK FACTORS; STROKE;

EID: 70350540798     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20090035     Document Type: Article

References (38)

1. Tunstall-Pedoe, H., Kuulasmaa, K., Amouyel, P., Arveiler, D., Rajakangas, A. M. and Pajak, A. (1994) Myocardial infarction and coronary deaths in the World Health Organization MONICA Project: registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 90, 583-612
2. Mitsios, N., Gaffney, J., Kumar, P., Krupinski, J., Kumar, S. and Slevin, M. (2006) Pathophysiology of acute ischaemic stroke: an analysis of common signalling mechanisms and identification of new molecular targets. Pathobiology 73, 159-175
3. Leys, D., Deplanque, D., Mounier-Vehier, C., Mackowiak-Cordoliani, M. A., Lucas, C. and Bordet, R. (2002) Stroke prevention: management of modifiable vascular risk factors. J. Neurol. 249, 507-517
4. Krupinski, J., Kaluza, J., Kumar, P., Kumar, S. and Wang, J. M. (1994) Role of angiogenesis in patients with cerebral ischaemic stroke. Stroke 25, 1794-1798
5. Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J. and Holash, J. (2000) Vascular-specific growth factors and blood vessel formation. Nature 407, 242-248
6. Yuan, H. T., Khankin, E. V., Karumanchi, S. A. and Parikh, S. M. (2009) Angiopoietin 2 is a partial agonist/antagonist of tie2 signaling in endothelium. Mol. Cell. Biol. 29, 2011-2022
7. Davis, S., Papadopoulos, N., Aldrich, T. H., Maisonpierre, P. C., Huang, T., Kovac, L., Xu, A., Leidich, R., Radziejewska, E., Rafique, A. et al. (2003) Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclustering. Nat. Struct. Biol. 10, 38-44
8. Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N. et al. (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277, 55-60
9. Parikh, S. M., Mammoto, T., Schultz, A., Yuan, H. T., Christiani, D., Karumanchi, S. A. and Sukhatme, V. P. (2006) Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med. 3, e46
10. Saharinen, P., Kerkela, K., Ekman, N., Marron, M., Brindle, N., Lee, G. M., Augustin, H., Koh, G. Y. and Alitalo, K. (2005) Multiple angiopoietin recombinant proteins activate the Tie1 receptor tyrosine kinase and promote its interaction with Tie2. J. Cell Biol. 169, 239-243
11. Scharpfenecker, M., Fiedler, U., Reiss, Y. and Augustin, H. G. (2005) The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism. J. Cell Sci. 118, 771-780
12. Harfouche, R. and Hussain, S. N. (2006) Signaling and regulation of endothelial cell survival by angiopoietin-2. Am. J. Physiol. Heart Circ. Physiol. 291, H1635-H1645
13. Kim, I., J. Kim, H., Moon, S. O., Kwak, H. J., Kim, N. G. and Koh, G. Y. (2000) Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Oncogene 19, 4549-4552
14. Teichert-Kuliszewska, K., Maisonpierre, P. C., Jones, N., Campbell, A. I., Master, Z., Bendeck, M. P., Alitalo, K., Dumont, D. J., Yancopoulos, G. D. and Stewart, D. J. (2001) Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2. Cardiovasc. Res. 49, 659-670
15. Goede, V., Schmidt, T., Kimmina, S., Kozian, D. and Augustin, H. G. (1998) Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis. Lab. Invest. 78, 1385-1394
16. Holash, J., Maisonpierre, P. C., Compton, D., Boland, P., Alexander, C. R., Zagzag, D., Yancopoulos, G. D. and Wiegand, S. J. (1999) Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284, 1994-1998
17. Stratmann, A., Risau, W. and Plate, K. H. (1998) Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am. J. Pathol. 153, 1459-1466
18. Zagzag, D., Hooper, A., Friedlander, D. R., Chan, W., Holash, J., Wiegand, S. J., Yancopoulos, G. D. and Grumet, M. (1999) In situ expression of angiopoietins in astrocytomas identifies angiopoietin-2 as an early marker of tumor angiogenesis. Exp. Neurol. 159, 391-400
19. Hanahan, D. (1997) Signaling vascular morphogenesis and maintenance. Science 277, 48-50
20. Holash, J., Wiegand, S. J. and Yancopoulos, G. D. (1999) New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 18, 5356-5362
21. Gale, N. W., Thurston, G., Hackett, S. F., Renard, R., Wang, Q., McClain, J., Martin, C., Witte, C., Witte, M. H., Jackson, H. et al. (2002) Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev. Cell 3, 411-423
22. Daly, C., Pasnikowski, E., Burova, E., Wong, V., Aldrich, T. H., Griffiths, J., Ioffe, E., Daly, T. J., Fandl, J. P., Papadopoulos, N., McDonald, D. M. et al. (2006) Angiopoietin-2 functions as an autocrine protective factor in stressed endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 103, 15491-15496
23. Lee, K.W., Lip, G. Y. and Blann, A. D. (2004) Plasma angiopoietin-1. angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes. Circulation 110, 2355-2360
24. Nadar, S. K., Blann, A., Beevers, D. G. and Lip, G. Y. (2005) Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)]. J. Intern. Med. 258, 336-343
25. Patel, J. V., Lim, H. S., Varughese, G. I., Hughes, E. A. and Lip, G. Y. (2008) Angiopoietin-2 levels as a biomarker of cardiovascular risk in patients with hypertension. Ann. Med. 40, 215-222
26. Li, Z., Sun, L., Zhang, H., Liao, Y., Wang, D., Zhao, B., Zhu, Z., Zhao, J., Ma, A., Han, Y. et al. (2003) Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke: a Multicenter Case-Control Study in China. Stroke 34, 2085-2090
27. Wang, Y., Zhang, W., Zhang, Y., Yang, Y., Sun, L., Hu, S., Chen, J., Zhang, C., Zheng, Y., Zhen, Y. et al. (2006) VKORC1 haplotypes are associated with arterial vascular diseases (stroke, coronary heart disease, and aortic dissection). Circulation 113, 1615-1623
28. Practice Management Information Corporation (1995) International Classification of Diseases, 9th revision. Clinical Modification, 4th edn, Practice Management Information Corporation (PMIC, ed.), Los Angeles
29. Miller, S. A., Dykes, D. D. and Polesky, H. F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16, 1215
30. Pritchard, J. K. and Rosenberg, N. A. (1999) Use of unlinked genetic markers to detect population stratification in association studies. Am. J. Hum. Genet. 65, 220-228
31. Williams, J. K., Armstrong, M. L. and Heistad, D. D. (1988) Vasa vasorum in atherosclerotic coronary arteries: response to vasoactive stimuli and regression of atherosclerosis. Circ. Res. 62, 515-523
32. Patterson, J. C. (1938) Capillary rupture with intimal hemorrhage as a causative factor in coronary thrombosis. Arch. Pathol. 25, 474-487
33. Mochizuki, Y., Nakamura, T., Kanetake, H. and Kanda, S. (2002) Angiopoietin 2 stimulates migration and tube-like structure formation of murine brain capillary endothelial cells through c-Fes and c-Fyn. J. Cell Sci. 115, 175-183
34. Post, S., Peeters, W., Busser, E., Lamers, D., Sluijter, J. P., Goumans, M. J., de Weger, R. A., Moll, F. L., Doevendans, P. A., Pasterkamp, G. and Vink, A. (2008) Balance between angiopoietin-1 and angiopoietin-2 is in favor of angiopoietin-2 in atherosclerotic plaques with high microvessel density. J. Vasc. Res. 45, 244-250
35. Wang, M. M., Klaus, J. A., Joh, H. D., Traystman, R. J. and Hurn, P. D. (2002) Postischemic angiogenic factor expression in stroke-prone rats. Exp. Neurol. 173, 283-288
36. Wardlaw, J. M., Sandercock, P. A., Dennis, M. S. and Starr, J. (2003) Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke 34, 806-812
37. Roviezzo, F., Tsigkos, S., Kotanidou, A., Bucci, M., Brancaleone, V., Cirino, G. and Papapetropoulos, A. (2005) Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage. J. Pharmacol. Exp. Ther. 314, 738-744
38. Zhu, Y., Lee, C., Shen, F., Du, R., Young, W. L. and Yang, G. Y. (2005) Angiopoietin-2 facilitates vascular endothelial growth factor-induced angiogenesis in the mature mouse brain. Stroke 36, 1533-1537